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Monday, November 19, 2018 
 
To the associate Editor-in-Chief 
 
Dear Dr. Leonard A. Kaminsky, 
On behalf of myself and my colleagues, I would like to thank you for the opportunity to submit a 
ƌĞǀŝƐĞĚ ǀĞƌƐŝŽŶ ŽĨ ƚŚĞ ŵĂŶƵƐĐƌŝƉƚ  SChanges in Physical Performance and their Association with 
Health Related Quality of Life in a Mixed Non-ischemic Cardiac Population ? to the Journal of 
Cardiopulmonary Rehabilitation and Prevention.  
We would also like to thank the reviewers for their valuable comments. Our detailed point-by-point 
response to these comments is provided below and our edits in the manuscript and the tables are 
indicated with red font. A  ?ĐůĞĂŶ ?ǀĞƌƐŝŽŶ of the manuscript and tables has also been submitted.  
We look forward to hearing your decision regarding our manuscript. 
 
Yours sincerely, 
 
First author  
  
&RYHU/HWWHU
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Ms. Ref. No.:  JCRP-D-18-00148 "Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic Cardiac 
Population" 
 
Comment ƵƚŚŽƌ ?ƌĞƉůǇ Action Taken / Manuscript revision 
Editor 
As you will note, I am recommending acceptance but 
with minor revision. This decision is based on a 
ƌĞǀŝĞǁĞƌ ?ƐĐŽŵŵĞŶƚƐƚŚĂƚĂƌĞŝŶĐůƵĚĞĚĂŶĚƚŚĞ
recommendation of the Associate Editor.    
We who like to thank the editor for their decision. 
We have undertaken all the requested editorial 
changes and all changes suggested by the reviewer. 
We hope this meets your expectations.    
 
Editorial changes  
-     Provide a complete postal mailing address for the 
corresponding author 
A complete postal mailing address for the 
corresponding author has been added to the title 
page 
 
-     Present references as described in the Instructions 
for Authors (e.g. doi should not be listed) 
The reference list has been corrected.  
-     The title page lists number of references as 47, 
however, the reference list has 52; please reduce this to 
no more than 50 references 
 
The number of references has been reduced to 50 
and number of references in the title page has been 
updated.  
 
-     List all abbreviations used in tables as a footnote to 
the table in alphabetical order formatted like this: 
Abbreviations: ALI, acute lung injury; ARDS, acute 
respiratory distress syndrome; BMI, body mass index; etc 
Has been corrected in all four tables.  
Reviewer #1 
#1. Regard to your comments on my suggestion for table 
2, I can not agree with your answer. Clear presentation 
of study results is important in scientific paper and 
readers in this journal may be smart enough to 
understand the main focus of this study. I still 
recommend you to show both scores at baseline and 
follow-up and the p-values for the statistical test to see 
the before and after difference. 
Table 2 has been changed and includes absolute 
follow-up scores and p-values  
The following has been added to the 
text 
 
 SSignificant changes were explored 
using a paired t-test ?Page 4, Line 85 
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#2. in addition, the number of subjects in baseline and 
follow-up is different for some items (e.g. peak Vo2, 
power, 6MWT). There should be follow-up losses but I 
think they have to be excluded from analysis. So the 
number in 6MWT should be just 314. 
 
We agree with the reviewer. This has already been 
taken into account in the analysis. All analyses only 
include the patients with a change score which 
varies for each variable. However, this was not taken 
into account in the baseline scores in table 2 but has 
now been corrected.  
 
#3. in line with comment 2, what was the sample size 
used for the correlation analysis (table 3). Was it same in 
each correlation analysis? 
What is the value in table 3? Maybe, correlation 
coefficient but it has to be described clearly in the table 
(e.g. The values are the correlation coefficients by 
Spearman correlation analysis). 
Where is the 95% CI in table 2? 
 
Based on this comment we have added the number 
of patients in the correlation analysis and changed 
the title of table 3.  
 
To our knowledge a 95% CI is already presented in 
table 2. We are therefore unsure about what is 
missing?  
The number of patients has been added 
in table 3 in line with the previously 
comment.  
Table 3 has been renamed to:  
 
 SAssociations between change scores in 
physical outcome measures  and health 
related quality of life calculated using 
^ƉĞĂƌŵĂŶ ?ƐĐŽƌƌĞůĂƚŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ? 
 
#4. Table 1: Please clarify your results presentation. For 
example, the values of categorical variables in the 
column of the mean(SD) may be the percent. 
Medical records may be just the medication. 
 
 
All categorical variables are already presented in 
percent. TŚĞĐŽůƵŵŶ SŵĞĂŶ ?^ ? ?ĐŚĂŶŐĞƐ 
throughout the table. However we have made this 
clear. 
 
 
Changes made in table 1: 
 
Medical records has been changed to 
medication and percentage has been 
added to clarify this.  
#5. Table 4: What was the sample size used for the 
regression analysis? 
Were the values in table 4 beta coefficient? Please clarify 
it in the table. Were the values the mean? 
What is heart diagnosis? Was it the patient type in table 
1? Clarify it. 
Why did you exclude other important confounders which 
may impact on the QoL and Physical fitness changes such 
as employment status, depression, NYHA class? 
The number of patients has been added to table 4.  
 
The mean in table 4 represents the slope of the best 
fitted line between the dependent and independent 
variable. We have clarified this in table 4 
 
Confounders were widely discussed before 
performing the analysis. Many variables are known 
to influence physical capacity and especially QOL, 
which has already been highlighted in the discussion 
section. Adjusting for all these variables will 1) 
Changes made in table 4: 
 
Mean, the mean represents the slope of 
the best fitted line between the 
Dependent and independent variables 
 
Heart diagnosis has been changed to 
patient type, as in table 1. 
 
 
4 | P a g e  
 
decrease the external validity of the findings as the 
population will become highly selective and 2) it will 
lower the power in the analysis for each included 
variable. Due to the clinical perspective of this paper 
we decided only to control for the most common 
clinical confounders - sex and age. We further 
controlled for patient type due to the difference in 
pathologies between the three included patient 
groups. The overall results showed a weak 
association between changes in physical capacity 
and QOL. From a clinical stand-point this tells us that 
an increase in physical capacity by itself is not the 
key to increased QOL. From our perspective this is a 
very important clinical statement.       
Reviewer #2 
The authors have included a rationale and detailed 
response to my concerns. In my opinion, they have 
adequately answered my concerns 
We appreciated this and think the comments 
previously provided from the reviewer have 
strengthened the paper. 
 
 
Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic 
Cardiac Population that Participate in Rehabilitation. 
 
 
Structured Abstract 
Purpose: 
Exercise-based cardiac rehabilitation (CR) improves physical performance and health-related 
quality of life (HRQoL). However, whether improvements in physical performance are associated 
with changes in HRQoL has not been adequately investigated in a non-ischemic cardiac population. 
Methods  
Patients who were ablated for atrial fibrillation, who underwent heart valve surgery or who were 
treated for infective endocarditis and who participated in one of three randomised control 
rehabilitation trials were eligible for the current study. Change in physical performance and HRQoL 
were measured before and after a 12-week exercise intervention. Physical performance was 
assessed using a cardiopulmonary exercise test, a 6-min walk test and a sit-to-stand test. HRQoL 
were assessed using the generic Short-Form-36 and the disease-specific HeartQoL questionnaire. 
6SHDUPDQ¶VFRUUHODWLRQFRHIILFLHQW UKRDQG OLQHDU UHJUHVVLRQVTXDQWLILHG WKHDVVRFLDWLRQEHWZHHQ 
changes in physical outcome measures and changes in HRQoL.  
Results 
A total of 344 patients were included (mean age 60.8 (11.6) years and 77% males). Associations 
between changes in physical outcome measures and HRQoL ranged from very weak to weak 
(6SHDUPDQ¶V FRUUHODWLon coefficient = -0.056-0.228). The observed associations were more 
dominant within physical dimensions of the HRQoL compared to mental or emotional dimensions. 
Adjusted for sex, age and diagnosis changes in physical performance explained no more than 20% 
of the variation in the HRQoL.  
Conclusion 
$EVWUDFW
Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic 
Cardiac Population that Participate in Rehabilitation. 
 
 
Our findings show that the positive improvement in HRQoL from exercise-based CR cannot simply 
be explained by an improvement in physical performance.  
 
Condensed Abstract  
Whether improvements in physical performance are associated with changes HRQoL has not been 
adequately investigated in a non-ischemic cardiac population. Data obtained from three randomised 
control cardiac rehabilitation trials showed that changes in physical performance explained no more 
than 20% of the variation in the HRQoL. 
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Introduction 1 
In recent years, HRQoL has been found to be an important predictor of adverse health outcomes 2 
(e.g. risk of readmission and mortality) across cardiac populations.1±5 Hence, clinical guidelines 3 
emphasize the healthcare services like CR need to  improve HRQoL for patients.6  4 
Exercise training has high priority in cardiac rehabilitation.7 Exercise-based CR is known to 5 
increase physical performance and HRQoL.8±11 However, whether a positive improvement in 6 
physical performance with exercise-based CR can explain changes in HRQoL is uncertain. Previous 7 
studies show conflicting results12±21 where some report a weak to moderate influence of physical 8 
performance on HRQoL.12,15±17,19,21,22 Most studies have utilized cross-sectional designs where 9 
physical performance is compared to HRQoL at baseline17,19±23 or at the end for a CR intervention.15 10 
To our knowledge, only one study,12 has investigated the association between changes over time in 11 
physical performance and HRQoL with a prospective design demonstrating that changes in peak 12 
oxygen uptake (VO2) after a 8-week exercise-based CR intervention for patients with ischemic 13 
heart disease, heart valve disease, and heart failure only explained 4% of the variation in two 14 
subscales in the Short Form Health Survey (SF-36) (³SK\VLFDO IXQFWLRQ´ DQG ³YLWDOLW\´).12 Since 15 
HRQoL has become an important outcome measure in CR a better understanding of the association 16 
between increased physical performance and its impact on HRQoL is needed.6 17 
Studies on whether increased physical performance has an impact on HRQoL are mainly conducted 18 
in patients with coronary heart diseases or heart failure.12,15±17,19,21±24 In non-ischaemic cardiac 19 
populations (e.g. atrial fibrillation, heart valve replacement, infective endocarditis or heart 20 
transplant recipients) the topic has barely been investigated. The difference in pathologies between 21 
ischaemic and non-ischaemic cardiac diagnoses may impact on the generalisability between the two 22 
0DQXVFULSW$OO0DQXVFULSW7H[W3DJHVLQ06:RUGIRUPDWLQFOXGLQJ5HIHUHQFHVDQG)LJXUH/HJHQGV
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic 
Cardiac Population that Participate in Rehabilitation. 
2 
 
 
 
groups.25 However, in non-ischaemic cardiac populations reduced HRQoL has also been reported 23 
and found to be associated with risk of readmission.1±3  24 
Several assessment methods are routinely applied in CR, for example, the cardiac pulmonary 25 
exercise test (CPET)26, cycle ergometer (power in watts), six-minute-walk test (6MWT), and sit-to-26 
stand test which provide additional physical outcome measures for physical performance. As a 27 
small number of studies have indicated the relationship between physical performance and HRQoL 28 
varies as a consequence of the outcome measurement used to evaluate physical performance.16,19,22 29 
Hence, different assessment methods may impact HRQoL to varying degrees which is particularly 30 
relevant in an intervention where one of the specific aims is to enhance HRQoL.     31 
The objectives of this study was to assess whether changes in physical performance are associated 32 
with changes in HRQoL measured with both generic and disease-specific instruments and whether 33 
this is related to the physical assessment methods in patients without ischemic heart disease who 34 
were ablated for atrial fibrillation, who underwent heart valve surgery or who were treated for 35 
infective endocarditis. 36 
Methods  37 
Patients in the current study all participated in one of three randomized controlled trials (RCTs) 38 
with a parallel design and conducted simultaneously as a part of the CopenHeart Project.27±31 A 39 
regional Ethical Committee (j.nr: H-1-2011-135, H-1-2011-157 & H-1-2011-129) approved the 40 
RCTs.  Data handling was approved by the Danish Data Protection Agency (j.nr. 2007-58-0015). 41 
Since all three RCTs have been described in detail and their effectiveness has been studied 42 
elsewhere, the following section briefly outlines the trials in relation to the objectives of the current 43 
study.27±31 Patients without ischemic heart disease who either were ablated for atrial fibrillation, 44 
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who underwent heart valve surgery or who were treated for infective endocarditis were included if 45 
they were over 18 years, able to understand and speak Danish, and had no musculoskeletal or organ 46 
disease precluding physical activity.27±31 Patients were randomized to either a comprehensive CR 47 
intervention or usual care.27,29,31 The intervention consisted of psycho-education and exercise 48 
training. The psycho-educational consultations were performed five times over a period of 6 months 49 
from hospital discharge either as face-to-face consultations or by telephone. Exercise training was 50 
initiated one month after hospital discharge and consisted of 36 exercise sessions performed over 12 51 
weeks. The exercise program was individually tailored and involved both aerobic and strength 52 
exercises. The programme could be performed either in supervised centre-based setting or a home-53 
based setting based on patients own preference. The participant¶s choice of settings did not impact 54 
the effect of the intervention.32  55 
The outcomes of the three RCTs were physical performance and patient-reported HRQoL. To 56 
evaluate physical performance patients underwent three objective assessment methods performed 57 
before and after the exercise intervention (e.g. one month and four months after hospital discharge). 58 
Detailed information about these tests have been described elsewhere.27,29,31  59 
Peak VO2 and maximum power (watts) were measured during a maximum CPET using a ramp 60 
protocol on a cycle ergometer. Physical performance was further assessed using the 6-min walk test 61 
(6MWT) and a sit-to-stand test. In the current study, HRQoL was assessed with both generic and 62 
disease-specific instruments and collected at baseline and six months after hospital discharge. The 63 
generic 36-item Short-Form Health Survey (SF-36)33 was used to assess patient-reported HRQoL 64 
and presented as mental component summary (MCS) and physical component summary (PCS) 65 
scores. The disease-specific HeartQoL 34,35 questionnaire was used to assess heart HRQoL with 66 
Global, Physical and Emotional scores.  67 
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Patient demographics, clinical variables and classification of disease severity were measured at 68 
baseline. For classification of disease severity, the New York Heart Association (NYHA) 69 
Functional Classification was used for patients who underwent heart valve surgery and for patients 70 
with infective endocarditis. The European Heart Rhythm Association (EHRA) score indicating 71 
atrial fibrillation-related symptoms was used in patients who underwent an ablation for atrial 72 
fibrillation. The Hospital Anxiety and Depression Scale (HADS)36 was used to screen for symptoms 73 
of anxiety and depression at baseline.   74 
Only patients who performed at least one of the exercise tests before and after the exercise 75 
intervention and who fulfilled at least one of the HRQoL questionaries at baseline and at six months 76 
were included in current study. Both the intervention and the control group from the three RCTs 77 
were included. A sub analysis adjusting for allocation to either the intervention or control group was 78 
performed.      79 
Statistical analyses  80 
Baseline demographics are presented as mean ± standard deviation (SD) for parametric data and as 81 
medians and interquartile ranges (IQR) for non-parametric data.   82 
To assess the strength of association between changes in physical performance and changes in 83 
HRQoL, change scores (post CR minus pre CR values) were calculated for all outcome measures. 84 
Significant changes were explored using a paired t-test.  6SHDUPDQ¶V correlation coefficient (rho) 85 
was used to calculate the association between change scores in physical outcome measures and 86 
HRQoL. The strength of the correlation was interpreted as suggested by Evans et al.37 with the 87 
absolute value for rho: very week (0.00-0.19), weak (0.20-0.39), moderate (0.40-0.59), strong (0.60-88 
0.79), and very strong (0.80-1.00). A univariate linear regression model was used to quantify the 89 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic 
Cardiac Population that Participate in Rehabilitation. 
5 
 
 
 
strength of association between changes in physical outcome measures and changes in HRQoL. 90 
Where univariate linear regression showed a significant relationship, a multivariate linear regression 91 
model was conducted controlling for age, sex and patient type. The coefficient of determination 92 
(R2) was calculated for all models. All statistical analyses were performed using the software SAS 93 
Enterprise Guide 5.1 (SAS Institute Inc., Cary, NC, USA). Level of statistical significant was 94 
expressed as a p < 0.05. 95 
Results  96 
In total, 474 patients were enrolled in the three RCTs.27±31 Of these patients, 344 were included in 97 
the current analysis as they performed at least one of the three exercise tests before and after the 98 
exercise intervention and had completed at least one of the HRQoL questionnaires at baseline and at 99 
six months. Participants and non-participants were similar; age (p=0.159), sex (p=0.151) and BMI 100 
(p=0.812). The mean age of the patients included in the study was 60.8 (± 11.6) years with the 101 
majority male (77%). Participant characteristics at baseline are presented in Table 1. Baseline and 102 
change scores (post intervention score minus pre intervention score) in physical outcome measures 103 
and HRQoL scores are reported in Table 2. 104 
Spearman correlations coefficients between change scores in physical outcome measures and 105 
HRQoL are presented in Table 3. The majority of the 20 associations were very weak (rho=0.00-106 
0.19) with four categorised as weak (rho=0.20-0.39). The four weak associations were found 107 
between the HeartQoL Global score and HeartQoL Physical score changes and maximum power 108 
(watts) changes (rho=0.209 and rho=0.204, respectively) and changes in sit-to-stand test (rho=0.228 109 
and rho=0.215, respectively).   110 
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Results from univariate and multivariate linear regression analysis are presented in Table 4. The 111 
change in peak VO2 showed statistically significant association with the SF-36 physical component 112 
score. However, findings were not significant when adjusted for sex, age and heart diagnosis in the 113 
multivariate model (mean change score = 0.128 with 95% CI: -0.077 to 0.334). Changes in 114 
maximum power (watts) showed statistically significant associations with the four out of five 115 
HRQoL scores. Only the SF-36 mental component and the HeartQoL Emotional scores were not 116 
significantly associated with changes in maximum power when adjusted for sex, age and diagnose. 117 
In the multivariate model, changes in maximum power (watts) explained from 5% to 17% of the 118 
changes in HRQoL (HeartQOL Emotional: R2 = 0.050, HeartQol physical score: R2 = 0.169). 119 
Changes in 6-MWT were only statistically significantly associated with changes in the SF-36 120 
physical component score - both in univariate (R2=0.026) and multivariate regression model 121 
(R2=0.164). Changes in the number of repetitions during the sit-to-stand test were statistically 122 
significantly associated with changes in SF-36 physical component score and all three dimensions 123 
in HeartQoL (Global, Emotional and Physical). When adjusted for sex, age and heart diagnosis, the 124 
R2 ranged from 5% to 20% (HeartQoL Emotional score R2 = 0.054, HeartQol physical score: R2 = 125 
0.200). Adjusting for allocation (intervention vs control) did not change the overall interpretation of 126 
the results. 127 
Discussion  128 
The objective of this study was to assess whether changes in physical performance are associated 129 
with changes in HRQoL in a mixed non-ischaemic cardiac population. Results showed very weak to 130 
weak associations between changes in physical performance outcomes measures and HRQoL. The 131 
observed associations between change scores in physical performance and HRQoL tended to be 132 
more dominant within physical dimensions of HRQoL compared to emotional dimensions. Still, 133 
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adjusted for sex, age and diagnosis, changes in physical performance never accounted for more than 134 
for 20% of the variation in the HRQoL.  135 
Exercise-based CR is known to increase physical performance and HRQoL.8,9  Previous studies 136 
investigating the association between physical performance and HRQoL show conflicting results 137 
spanning very weak to moderate associations.12,15±17,19,21,22 The understanding of this association 138 
between physical performance and HRQoL has mainly been investigated in patients with ischemic 139 
heart disease or heart failure using a cross-sectional design and therefore not investigated from 140 
improvement over time.15,17,19±23 In addition to our study, changes in physical performance and its 141 
associations to HRQoL have only been investigated in one other prospective study.12  Andersen et 142 
al. compared changes in SF-36 with changes in peak VO2 after an 8-week exercise-based CR 143 
intervention conducted in patients with ischemic heart disease, heart valve disease, or heart failure. 144 
They found that peak VO2 explained 4% of the changes in SF-36 physical function and vitality 145 
subscale scores.12 In contrast to our study, Andersen et al. did not show a statistically significant 146 
associations between changes in peak VO2 and changes in SF-36 physical component score with a 147 
mean change of - &,í WR. Although this difference may be due to a lack of 148 
power in the Andersen study with 166 patients compared to 341 in our study, the 4% explained 149 
variance in SF-36 subscale physical function and vitality score with change in physical performance 150 
reported by Andersen et al. 12 is similar to the 2% (R2) seen in our crude estimate of SF-36 (R2 = 151 
0.016 SF-36 physical component score). This indicates similarities in findings between the patient 152 
populations between the two studies (Patients with ischemic heart disease, heart valve disease, or 153 
heart failure VS patients ablated for atrial fibrillation, undergone heart valve surgery or treated for 154 
infective endocarditis)  However, when we adjusted for age, sex and heart diagnosis, the changes in 155 
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peak VO2 explained about 15% of the changes in SF-36 physical component score (R2 = 0.153) 156 
which indicate a variation between age, sex and each individual heart diagnosis.  157 
As the first study to compare changes in physical performance measures over time to changes in 158 
both HRQoL measured with both generic and disease-specific instruments, we observed 159 
associations correlating predominantly with the physical dimensions of HRQoL. However, the 160 
associations between physical performance and the HeartQoL physical score were weak with only 161 
very weak associations with the SF-36 PCS score. This difference in the strength of associations 162 
between physical dimensions measured by generic and disease-specific instruments could possibly 163 
be explained by the fact that the HeartQoL is a heart disease-specific questionnaire where physical 164 
items are more common in cardiac patients across conditions than physical items used in generic 165 
questionnaires.  166 
A few cross sectional design studies have investigated how different physical performance outcome 167 
measures correlate with HRQoL.16,19,22 Unfortunately, heterogeneity due to different outcome 168 
measures, RCT patient populations and HRQoL measures complicate comparison across studies. 169 
Collected in a prospective study, our findings indicate that certain physical outcome measures can, 170 
to a greater extent, explain the variation in HRQoL than others. For instance, changes in all four 171 
physical outcome measures explained 15% to18% of the variation in SF-36 physical component 172 
score but only changes in maximum power and repetitions during sit-to-stand test explained 173 
changes in HRQoL (HeartQoL Global and Physical score). Changes in power and repetitions during 174 
sit-to-stand test explained from 15% to 18% of the variation on the HeartQoL Global score and 18% 175 
to 20% of the variation in the HeartQoL Physical score. One explanation for why maximum power 176 
and sit-to-stand test better explain variations in disease-specific related HRQoL than peak VO2 and 177 
6MWT could be that these are surrogate measures for strength in the lower extremities. In elderly 178 
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participants, previous research have found an association between lower limb strength and physical 179 
function38,39 and, in patients with diabetes mellitus, lower limb strength is known to correlate with 180 
HRQoL.40   181 
 182 
Evidence shows that exercise-based CR increases both physical performance and HRQoL across 183 
cardiac patients groups.8,9,41 However, changes in physical performance explain little of the changes 184 
observed in HRQoL. Other mechanisms and elements than increased physical performance must be 185 
explored before the impact of exercise-based CR on HRQoL will be fully understood. For instance 186 
depression and anxiety scores are known predictions for HRQoL in cardiac patients and are 187 
positively influenced by exercise-based CR.42,43 Baseline levels in physical performance and sizes 188 
of improvement may also affect the association. A low physical performance level at baseline will 189 
perhaps to a larger extent affect association with HRQoL in comparison to a performance level that 190 
does not prevent a patient from daily routines. According to the Cardiac Rehabilitation Section of 191 
the European Association of Cardiovascular Prevention and Rehabilitation exercise training alone 192 
cannot be categorised as CR. Hence exercise-based CR will normally contains patient-education or 193 
psychological counseling likely to affect HRQoL.44,45  194 
Strength and limitation 195 
To our knowledge this is the largest study to investigate the relationship between physical 196 
performance and HRQoL based on change scores from patients who participated in exercise-based 197 
CR. Further, the study is the first to compare intervention changes obtained from different physical 198 
outcome measures to changes in HRQoL measured by both generic and disease-specific 199 
instruments. 200 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic 
Cardiac Population that Participate in Rehabilitation. 
10 
 
 
 
Most of the previous studies on the topic have been conducted in patients with ischemic heart 201 
disease or heart failure.12,15±17,19,21,22 In contrast, we analysed a mixed group of non-ischemic cardiac 202 
patients with ablation for atrial fibrillation, or who underwent heart valve surgery or who were 203 
treated for infective endocarditis recognizing that the three pathologies are very different. However, 204 
this was taken into consideration by adjusting for diagnosis in our analysis. Following this line, the 205 
generalisability of our findings is likely to be limited to the three patients groups include in this 206 
study. However, compared to the findings of Andersen et al.46 who included patients with ischemic 207 
heart disease, heart valve disease or heart failure, our findings are remarkably similar.  208 
All our regression analyses were based on the underlying assumption of linearity between the 209 
independent and dependent variables. Complete linearity is however hypothetical and it is not 210 
known how this affects our results.47 For instance, we cannot verify whether different levels in 211 
physical performance or HRQoL would differentially impact the observed associations. Further, the 212 
study performs multiple comparisons without correction of the p-values. The rational is that the 213 
probability of a type I error cannot be lowered without increasing the probability of a type II error.48 214 
As this is an explorative study, solid conclusions cannot be drawn but help generate strong 215 
hypotheses that must be tested by a future study.49 Hence, it would be more appropriate to generate 216 
a possible significant association then to miss out on a type I error.48        217 
2IWKHSDWLHQWLQFOXGHGLQWKHWKUHH5&7¶VRQO\IXOILOOHGWKHLQFOXVLRQFULWHULDLQRXUstudy - 218 
corresponding to an attrition rate of 27%. In clinical trials a drop-out rate of approximately 15-20 % 219 
can be expected.50 Particularly in patients with non-ischemic cardiac conditions readmission rates 220 
are high where patients who undergo heart valve surgery or have endocarditis, readmission rates 221 
one year after hospital discharge are as high as 56% and 65%, respectively.1,2 So despite, a drop-out 222 
rate of 27%, our data still likely reflect those patients who participate in exercise-based CR. 223 
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Conclusion  224 
Both physical performance and HRQoL are improved with exercise-based CR in the current study. 225 
Nevertheless, our findings demonstrate that changes in physical performance only have a very weak 226 
to weak association with changes in HRQoL. The magnitude of changes in HRQoL explained by 227 
changes in physical performance are, not surprisingly, more evident in the physical dimensions of 228 
HRQoL. Unlike peak VO2, physical outcome measures reflecting lower limb strength may explain 229 
variation in HRQoL. Overall, our findings show that the positive impact of exercise-based CR on 230 
HRQoL cannot simply be explained by an increase in physical performance. Other mechanisms and 231 
elements must therefore be investigated before impact of exercise-based CR on HRQoL is fully 232 
understood. 233 
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Introduction 1 
In recent years, HRQoL has been found to be an important predictor of adverse health outcomes 2 
(e.g. risk of readmission and mortality) across cardiac populations.1±5 Hence, clinical guidelines 3 
emphasize the healthcare services like CR need to  improve HRQoL for patients.6  4 
Exercise training has high priority in cardiac rehabilitation.7 Exercise-based CR is known to 5 
increase physical performance and HRQoL.8±11 However, whether a positive improvement in 6 
physical performance with exercise-based CR can explain changes in HRQoL is uncertain. Previous 7 
studies show conflicting results12±21 where some report a weak to moderate influence of physical 8 
performance on HRQoL.12,15±17,19,21,22 Most studies have utilized cross-sectional designs where 9 
physical performance is compared to HRQoL at baseline17,19±23 or at the end for a CR intervention.15 10 
To our knowledge, only one study,12 has investigated the association between changes over time in 11 
physical performance and HRQoL with a prospective design demonstrating that changes in peak 12 
oxygen uptake (VO2) after a 8-week exercise-based CR intervention for patients with ischemic 13 
heart disease, heart valve disease, and heart failure only explained 4% of the variation in two 14 
subscales in the Short Form Health Survey (SF-36) (³SK\VLFDO IXQFWLRQ´ DQG ³YLWDOLW\´).12 Since 15 
HRQoL has become an important outcome measure in CR a better understanding of the association 16 
between increased physical performance and its impact on HRQoL is needed.6 17 
Studies on whether increased physical performance has an impact on HRQoL are mainly conducted 18 
in patients with coronary heart diseases or heart failure.12,15±17,19,21±24 In non-ischaemic cardiac 19 
populations (e.g. atrial fibrillation, heart valve replacement, infective endocarditis or heart 20 
transplant recipients) the topic has barely been investigated. The difference in pathologies between 21 
ischaemic and non-ischaemic cardiac diagnoses may impact on the generalisability between the two 22 
0DQXVFULSW$OO0DQXVFULSW7H[W3DJHVLQ06:RUGIRUPDWLQFOXGLQJ5HIHUHQFHVDQG)LJXUH/HJHQGV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groups.25 However, in non-ischaemic cardiac populations reduced HRQoL has also been reported 23 
and found to be associated with risk of readmission.1±3  24 
Several assessment methods are routinely applied in CR, for example, the cardiac pulmonary 25 
exercise test (CPET)26, cycle ergometer (power in watts), six-minute-walk test (6MWT), and sit-to-26 
stand test which provide additional physical outcome measures for physical performance. As a 27 
small number of studies have indicated the relationship between physical performance and HRQoL 28 
varies as a consequence of the outcome measurement used to evaluate physical performance.16,19,22 29 
Hence, different assessment methods may impact HRQoL to varying degrees which is particularly 30 
relevant in an intervention where one of the specific aims is to enhance HRQoL.     31 
The objectives of this study was to assess whether changes in physical performance are associated 32 
with changes in HRQoL measured with both generic and disease-specific instruments and whether 33 
this is related to the physical assessment methods in patients without ischemic heart disease who 34 
were ablated for atrial fibrillation, who underwent heart valve surgery or who were treated for 35 
infective endocarditis. 36 
Methods  37 
Patients in the current study all participated in one of three randomized controlled trials (RCTs) 38 
with a parallel design and conducted simultaneously as a part of the CopenHeart Project.27±31 A 39 
regional Ethical Committee (j.nr: H-1-2011-135, H-1-2011-157 & H-1-2011-129) approved the 40 
RCTs.  Data handling was approved by the Danish Data Protection Agency (j.nr. 2007-58-0015). 41 
Since all three RCTs have been described in detail and their effectiveness has been studied 42 
elsewhere, the following section briefly outlines the trials in relation to the objectives of the current 43 
study.27±31 Patients without ischemic heart disease who either were ablated for atrial fibrillation, 44 
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who underwent heart valve surgery or who were treated for infective endocarditis were included if 45 
they were over 18 years, able to understand and speak Danish, and had no musculoskeletal or organ 46 
disease precluding physical activity.27±31 Patients were randomized to either a comprehensive CR 47 
intervention or usual care.27,29,31 The intervention consisted of psycho-education and exercise 48 
training. The psycho-educational consultations were performed five times over a period of 6 months 49 
from hospital discharge either as face-to-face consultations or by telephone. Exercise training was 50 
initiated one month after hospital discharge and consisted of 36 exercise sessions performed over 12 51 
weeks. The exercise program was individually tailored and involved both aerobic and strength 52 
exercises. The programme could be performed either in supervised centre-based setting or a home-53 
based setting based on patients own preference. The participant¶s choice of settings did not impact 54 
the effect of the intervention.32  55 
The outcomes of the three RCTs were physical performance and patient-reported HRQoL. To 56 
evaluate physical performance patients underwent three objective assessment methods performed 57 
before and after the exercise intervention (e.g. one month and four months after hospital discharge). 58 
Detailed information about these tests have been described elsewhere.27,29,31  59 
Peak VO2 and maximum power (watts) were measured during a maximum CPET using a ramp 60 
protocol on a cycle ergometer. Physical performance was further assessed using the 6-min walk test 61 
(6MWT) and a sit-to-stand test. In the current study, HRQoL was assessed with both generic and 62 
disease-specific instruments and collected at baseline and six months after hospital discharge. The 63 
generic 36-item Short-Form Health Survey (SF-36)33 was used to assess patient-reported HRQoL 64 
and presented as mental component summary (MCS) and physical component summary (PCS) 65 
scores. The disease-specific HeartQoL 34,35 questionnaire was used to assess heart HRQoL with 66 
Global, Physical and Emotional scores.  67 
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Patient demographics, clinical variables and classification of disease severity were measured at 68 
baseline. For classification of disease severity, the New York Heart Association (NYHA) 69 
Functional Classification was used for patients who underwent heart valve surgery and for patients 70 
with infective endocarditis. The European Heart Rhythm Association (EHRA) score indicating 71 
atrial fibrillation-related symptoms was used in patients who underwent an ablation for atrial 72 
fibrillation. The Hospital Anxiety and Depression Scale (HADS)36 was used to screen for symptoms 73 
of anxiety and depression at baseline.   74 
Only patients who performed at least one of the exercise tests before and after the exercise 75 
intervention and who fulfilled at least one of the HRQoL questionaries at baseline and at six months 76 
were included in current study. Both the intervention and the control group from the three RCTs 77 
were included. A sub analysis adjusting for allocation to either the intervention or control group was 78 
performed.      79 
Statistical analyses  80 
Baseline demographics are presented as mean ± standard deviation (SD) for parametric data and as 81 
medians and interquartile ranges (IQR) for non-parametric data.   82 
To assess the strength of association between changes in physical performance and changes in 83 
HRQoL, change scores (post CR minus pre CR values) were calculated for all outcome measures. 84 
Significant changes were explored using a paired t-test.  6SHDUPDQ¶V correlation coefficient (rho) 85 
was used to calculate the association between change scores in physical outcome measures and 86 
HRQoL. The strength of the correlation was interpreted as suggested by Evans et al.37 with the 87 
absolute value for rho: very week (0.00-0.19), weak (0.20-0.39), moderate (0.40-0.59), strong (0.60-88 
0.79), and very strong (0.80-1.00). A univariate linear regression model was used to quantify the 89 
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strength of association between changes in physical outcome measures and changes in HRQoL. 90 
Where univariate linear regression showed a significant relationship, a multivariate linear regression 91 
model was conducted controlling for age, sex and patient type. The coefficient of determination 92 
(R2) was calculated for all models. All statistical analyses were performed using the software SAS 93 
Enterprise Guide 5.1 (SAS Institute Inc., Cary, NC, USA). Level of statistical significant was 94 
expressed as a p < 0.05. 95 
Results  96 
In total, 474 patients were enrolled in the three RCTs.27±31 Of these patients, 344 were included in 97 
the current analysis as they performed at least one of the three exercise tests before and after the 98 
exercise intervention and had completed at least one of the HRQoL questionnaires at baseline and at 99 
six months. Participants and non-participants were similar; age (p=0.159), sex (p=0.151) and BMI 100 
(p=0.812). The mean age of the patients included in the study was 60.8 (± 11.6) years with the 101 
majority male (77%). Participant characteristics at baseline are presented in Table 1. Baseline and 102 
change scores (post intervention score minus pre intervention score) in physical outcome measures 103 
and HRQoL scores are reported in Table 2. 104 
Spearman correlations coefficients between change scores in physical outcome measures and 105 
HRQoL are presented in Table 3. The majority of the 20 associations were very weak (rho=0.00-106 
0.19) with four categorised as weak (rho=0.20-0.39). The four weak associations were found 107 
between the HeartQoL Global score and HeartQoL Physical score changes and maximum power 108 
(watts) changes (rho=0.209 and rho=0.204, respectively) and changes in sit-to-stand test (rho=0.228 109 
and rho=0.215, respectively).   110 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Changes in Physical Performance and their Association with Health Related Quality of Life in a Mixed Non-ischemic 
Cardiac Population that Participate in Rehabilitation. 
6 
 
 
 
Results from univariate and multivariate linear regression analysis are presented in Table 4. The 111 
change in peak VO2 showed statistically significant association with the SF-36 physical component 112 
score. However, findings were not significant when adjusted for sex, age and heart diagnosis in the 113 
multivariate model (mean change score = 0.128 with 95% CI: -0.077 to 0.334). Changes in 114 
maximum power (watts) showed statistically significant associations with the four out of five 115 
HRQoL scores. Only the SF-36 mental component and the HeartQoL Emotional scores were not 116 
significantly associated with changes in maximum power when adjusted for sex, age and diagnose. 117 
In the multivariate model, changes in maximum power (watts) explained from 5% to 17% of the 118 
changes in HRQoL (HeartQOL Emotional: R2 = 0.050, HeartQol physical score: R2 = 0.169). 119 
Changes in 6-MWT were only statistically significantly associated with changes in the SF-36 120 
physical component score - both in univariate (R2=0.026) and multivariate regression model 121 
(R2=0.164). Changes in the number of repetitions during the sit-to-stand test were statistically 122 
significantly associated with changes in SF-36 physical component score and all three dimensions 123 
in HeartQoL (Global, Emotional and Physical). When adjusted for sex, age and heart diagnosis, the 124 
R2 ranged from 5% to 20% (HeartQoL Emotional score R2 = 0.054, HeartQol physical score: R2 = 125 
0.200). Adjusting for allocation (intervention vs control) did not change the overall interpretation of 126 
the results. 127 
Discussion  128 
The objective of this study was to assess whether changes in physical performance are associated 129 
with changes in HRQoL in a mixed non-ischaemic cardiac population. Results showed very weak to 130 
weak associations between changes in physical performance outcomes measures and HRQoL. The 131 
observed associations between change scores in physical performance and HRQoL tended to be 132 
more dominant within physical dimensions of HRQoL compared to emotional dimensions. Still, 133 
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adjusted for sex, age and diagnosis, changes in physical performance never accounted for more than 134 
for 20% of the variation in the HRQoL.  135 
Exercise-based CR is known to increase physical performance and HRQoL.8,9  Previous studies 136 
investigating the association between physical performance and HRQoL show conflicting results 137 
spanning very weak to moderate associations.12,15±17,19,21,22 The understanding of this association 138 
between physical performance and HRQoL has mainly been investigated in patients with ischemic 139 
heart disease or heart failure using a cross-sectional design and therefore not investigated from 140 
improvement over time.15,17,19±23 In addition to our study, changes in physical performance and its 141 
associations to HRQoL have only been investigated in one other prospective study.12  Andersen et 142 
al. compared changes in SF-36 with changes in peak VO2 after an 8-week exercise-based CR 143 
intervention conducted in patients with ischemic heart disease, heart valve disease, or heart failure. 144 
They found that peak VO2 explained 4% of the changes in SF-36 physical function and vitality 145 
subscale scores.12 In contrast to our study, Andersen et al. did not show a statistically significant 146 
associations between changes in peak VO2 and changes in SF-36 physical component score with a 147 
mean change of - &,í WR. Although this difference may be due to a lack of 148 
power in the Andersen study with 166 patients compared to 341 in our study, the 4% explained 149 
variance in SF-36 subscale physical function and vitality score with change in physical performance 150 
reported by Andersen et al. 12 is similar to the 2% (R2) seen in our crude estimate of SF-36 (R2 = 151 
0.016 SF-36 physical component score). This indicates similarities in findings between the patient 152 
populations between the two studies (Patients with ischemic heart disease, heart valve disease, or 153 
heart failure VS patients ablated for atrial fibrillation, undergone heart valve surgery or treated for 154 
infective endocarditis)  However, when we adjusted for age, sex and heart diagnosis, the changes in 155 
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peak VO2 explained about 15% of the changes in SF-36 physical component score (R2 = 0.153) 156 
which indicate a variation between age, sex and each individual heart diagnosis.  157 
As the first study to compare changes in physical performance measures over time to changes in 158 
both HRQoL measured with both generic and disease-specific instruments, we observed 159 
associations correlating predominantly with the physical dimensions of HRQoL. However, the 160 
associations between physical performance and the HeartQoL physical score were weak with only 161 
very weak associations with the SF-36 PCS score. This difference in the strength of associations 162 
between physical dimensions measured by generic and disease-specific instruments could possibly 163 
be explained by the fact that the HeartQoL is a heart disease-specific questionnaire where physical 164 
items are more common in cardiac patients across conditions than physical items used in generic 165 
questionnaires.  166 
A few cross sectional design studies have investigated how different physical performance outcome 167 
measures correlate with HRQoL.16,19,22 Unfortunately, heterogeneity due to different outcome 168 
measures, RCT patient populations and HRQoL measures complicate comparison across studies. 169 
Collected in a prospective study, our findings indicate that certain physical outcome measures can, 170 
to a greater extent, explain the variation in HRQoL than others. For instance, changes in all four 171 
physical outcome measures explained 15% to18% of the variation in SF-36 physical component 172 
score but only changes in maximum power and repetitions during sit-to-stand test explained 173 
changes in HRQoL (HeartQoL Global and Physical score). Changes in power and repetitions during 174 
sit-to-stand test explained from 15% to 18% of the variation on the HeartQoL Global score and 18% 175 
to 20% of the variation in the HeartQoL Physical score. One explanation for why maximum power 176 
and sit-to-stand test better explain variations in disease-specific related HRQoL than peak VO2 and 177 
6MWT could be that these are surrogate measures for strength in the lower extremities. In elderly 178 
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participants, previous research have found an association between lower limb strength and physical 179 
function38,39 and, in patients with diabetes mellitus, lower limb strength is known to correlate with 180 
HRQoL.40   181 
 182 
Evidence shows that exercise-based CR increases both physical performance and HRQoL across 183 
cardiac patients groups.8,9,41 However, changes in physical performance explain little of the changes 184 
observed in HRQoL. Other mechanisms and elements than increased physical performance must be 185 
explored before the impact of exercise-based CR on HRQoL will be fully understood. For instance 186 
depression and anxiety scores are known predictions for HRQoL in cardiac patients and are 187 
positively influenced by exercise-based CR.42,43 Baseline levels in physical performance and sizes 188 
of improvement may also affect the association. A low physical performance level at baseline will 189 
perhaps to a larger extent affect association with HRQoL in comparison to a performance level that 190 
does not prevent a patient from daily routines. According to the Cardiac Rehabilitation Section of 191 
the European Association of Cardiovascular Prevention and Rehabilitation exercise training alone 192 
cannot be categorised as CR. Hence exercise-based CR will normally contains patient-education or 193 
psychological counseling likely to affect HRQoL.44,45  194 
Strength and limitation 195 
To our knowledge this is the largest study to investigate the relationship between physical 196 
performance and HRQoL based on change scores from patients who participated in exercise-based 197 
CR. Further, the study is the first to compare intervention changes obtained from different physical 198 
outcome measures to changes in HRQoL measured by both generic and disease-specific 199 
instruments. 200 
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Most of the previous studies on the topic have been conducted in patients with ischemic heart 201 
disease or heart failure.12,15±17,19,21,22 In contrast, we analysed a mixed group of non-ischemic cardiac 202 
patients with ablation for atrial fibrillation, or who underwent heart valve surgery or who were 203 
treated for infective endocarditis recognizing that the three pathologies are very different. However, 204 
this was taken into consideration by adjusting for diagnosis in our analysis. Following this line, the 205 
generalisability of our findings is likely to be limited to the three patients groups include in this 206 
study. However, compared to the findings of Andersen et al.46 who included patients with ischemic 207 
heart disease, heart valve disease or heart failure, our findings are remarkably similar.  208 
All our regression analyses were based on the underlying assumption of linearity between the 209 
independent and dependent variables. Complete linearity is however hypothetical and it is not 210 
known how this affects our results.47 For instance, we cannot verify whether different levels in 211 
physical performance or HRQoL would differentially impact the observed associations. Further, the 212 
study performs multiple comparisons without correction of the p-values. The rational is that the 213 
probability of a type I error cannot be lowered without increasing the probability of a type II error.48 214 
As this is an explorative study, solid conclusions cannot be drawn but help generate strong 215 
hypotheses that must be tested by a future study.49 Hence, it would be more appropriate to generate 216 
a possible significant association then to miss out on a type I error.48        217 
2IWKHSDWLHQWLQFOXGHGLQWKHWKUHH5&7¶VRQO\IXOILOOHGWKHLQFOXVLRQFULWHULDLQRXUstudy - 218 
corresponding to an attrition rate of 27%. In clinical trials a drop-out rate of approximately 15-20 % 219 
can be expected.50 Particularly in patients with non-ischemic cardiac conditions readmission rates 220 
are high where patients who undergo heart valve surgery or have endocarditis, readmission rates 221 
one year after hospital discharge are as high as 56% and 65%, respectively.1,2 So despite, a drop-out 222 
rate of 27%, our data still likely reflect those patients who participate in exercise-based CR. 223 
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Conclusion  224 
Both physical performance and HRQoL are improved with exercise-based CR in the current study. 225 
Nevertheless, our findings demonstrate that changes in physical performance only have a very weak 226 
to weak association with changes in HRQoL. The magnitude of changes in HRQoL explained by 227 
changes in physical performance are, not surprisingly, more evident in the physical dimensions of 228 
HRQoL. Unlike peak VO2, physical outcome measures reflecting lower limb strength may explain 229 
variation in HRQoL. Overall, our findings show that the positive impact of exercise-based CR on 230 
HRQoL cannot simply be explained by an increase in physical performance. Other mechanisms and 231 
elements must therefore be investigated before impact of exercise-based CR on HRQoL is fully 232 
understood. 233 
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Table 1: Patient characteristics 
 
 N Mean (SD) 
   
Age (years) 344 60.8 (11.6) 
BMI (kg/m2) 332 26.0 (4.4) 
   
Sex   % 
Male  266 77 
Female  78 23 
   
Employment status  % 
Employed 173 50.3 
Unemployed 171 49.7 
   
Marital status  % 
Living alone 68 19.8 
Living with partner 276 80.2 
   
Patient type  % 
Radiofrequency ablation 151 43.9 
Valve replacement 107 31.1 
Infective endocarditis 86 25.0 
   
NYHA/EHRA class  % 
I 80 23.7 
II 161 47.6 
III 92 27.2 
IV 5 1.5 
   
Medication  % 
Warfarin 237 69.5 
Beta-blockers  141 41.4 
Statin 114 33.4 
Calcium antagonists 58 17.0 
   
HADS  Median (IQR) 
Depression 343 2.0 (1.0-4.0) 
Anxiety  344 4.0 (2.0-7.0) 
 
Abbreviations: EHRA, European Heart Rhythm Association (EHRA) score of atrial fibrillation 
related symptoms; HADS, Hospital Anxiety and Depression Scale; IQR, Interquartile range 
N, Number of patients; NYHA class; the New York Heart Association (NYHA) Functional 
Classification. 
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Table 2: Baseline scores and the changes scores for both physical outcome measurements and health related quality of 
life 
 
N 
Score at baseline  
Mean (95% CI) 
Score at follow-up 
Mean (95% CI) 
Change score ?* 
Mean (95% CI) 
Physical 
performance 
 
 
  
Peak Vo2 (ml/min/kg) 341 22.6 (21.7-23.4) 24.7 (23.9-25.6) 2.2 (1.7-2.7) 
Maximum power 
(watts) 
341 149.1 (143.2-155.1) 166.5 (159.7-173.3) 17.4 (14.3-20.4) 
6 min walk test 
(meter) 
314 558.0 (546.6-569.4) 592.6 (581.3-603.3) 34.6 (26.8-42.3) 
Stand-to-sit test 
(repetitions) 
315 14.8 (14.3-15.3) 17.1 (16.4-17.7) 2.3 (1.9-2.6) 
     
SF-36     
Mental component 
score 
337 47.3 (46.2-48.4) 53.3 (52.3-54.3) 6.0 (4.8-7.1) 
Physical component 
score 
337 43.1 (42.1-44.1) 50.2 (49.3-51.2) 7.0 (6.1-8.3) 
     
HeartQol     
Global 342 1.7 (1.6-1.8) 2.5 (2.4-2.5) 0.8 (0.7-0.8) 
Emotional 342 2.0 (1.9-2.1) 2.5 (2.4-2.6) 0.5 (0.4-0.6) 
Physical 342 1.6 (1.5-1.7) 2.5 (2.4-2.5) 0.9 (0.8-1.0) 
     
Abbreviations: N, Number of patients; Peak Vo2, Peak oxygen uptake; SF-36, 36-items Short Form Health Survey; 95% CI, 
95 % confidence interval. 
 ?Post intervention score minus pre intervention score 
*Wч ? ? ? ?ĨŽƌĂůůĐŚĂŶŐĞƐĨƌŽŵďĂƐĞůŝŶĞƚŽĨŽůůŽǁ-up. 
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315 14.8 (14.3-15.3) 17.1 (16.4-17.7) 2.3 (1.9-2.6) 
     
SF-36     
Mental component 
score 
337 47.3 (46.2-48.4) 53.3 (52.3-54.3) 6.0 (4.8-7.1) 
Physical component 
score 
337 43.1 (42.1-44.1) 50.2 (49.3-51.2) 7.0 (6.1-8.3) 
     
HeartQol     
Global 342 1.7 (1.6-1.8) 2.5 (2.4-2.5) 0.8 (0.7-0.8) 
Emotional 342 2.0 (1.9-2.1) 2.5 (2.4-2.6) 0.5 (0.4-0.6) 
Physical 342 1.6 (1.5-1.7) 2.5 (2.4-2.5) 0.9 (0.8-1.0) 
     
Abbreviations: N, Number of patients; Peak Vo2, Peak oxygen uptake; SF-36, 36-items Short Form Health Survey; 95% CI, 
95 % confidence interval. 
 ?Post intervention score minus pre intervention score 
*Wч ? ? ? ?ĨŽƌĂůůĐŚĂŶŐĞƐĨƌŽŵďĂƐĞůŝŶĞƚŽĨŽůůŽǁ-up. 
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Table 3: Associations between change scores in physical outcome measures  and health related quality of 
life calculated ƵƐŝŶŐ^ƉĞĂƌŵĂŶ ?ƐĐŽƌƌĞůĂƚŝŽŶĐŽĞĨĨŝĐŝĞŶƚ 
  
SF36 
MCS 
SF36 
PCS 
HeartQol 
global 
HeartQoL 
Emotionel 
HeartQoL 
Physical 
Peak VO2 
(ml/kg/min) 
-0.045 
(n=334) 
0.154 
(n=334) 
0.110 
(n=339) 
0.064 
(n=339) 
0.115 
(n=339) 
Maximum 
power (W) 
0.005 
(n=334) 
0.187 
(n=334) 
0.209 
(n=339) 
0.128 
(n=339) 
0.204 
(n=339) 
6-MWT 
-0.056 
(n=307) 
0.143 
(n=307) 
0.071 
(n=313) 
0.026 
(n=313) 
0.080 
(n=313) 
Sit-to-stand 
test 
0.019 
(n=308) 
0.162 
(n=308) 
0.228 
(n=314) 
0.169 
(n=314) 
0.215 
(n=314) 
Abbreviations: SF-36 MCS, SF-36 mental component scale; SF-36 PCS, SF-36 physical component scale; 6-
MWT, 6 minutes walk test; n, Number of patients; 95% CI, 95 % confidence interval. 
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(n=313) 
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(n=313) 
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Sit-to-stand 
test 
0.019 
(n=308) 
0.162 
(n=308) 
0.228 
(n=314) 
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Table 4: Univariate and multivariate linear regression of changes score in physical performance measurements and health related quality of life 
  
SF36 
MCS 
SF36 
PCS 
HeartQol 
Global 
HeartQOL 
Emotional 
HeartQOL 
Physical 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Peak VO2 (n=334) (n=334) (n=339) (n=339) (n=339) 
Crude estimate -0.075 (-0.317 - 0.166) 0.252 (0.036 - 0.468)* 0.011 (-0.004- 0.027) 0.012 (-0.006 - 0.031) 0.011 (-0.006 - 0.029) 
 R2 = 0.001 R2 = 0.016 R2 = 0.006 R2 = 0.005 R2 = 0.005 
Adjusted estimate   - 0.128 (-0.077 - 0.334) - - - 
  R2 = 0.153    
      
Maximum 
power (watts) 
(n=334) (n=334) (n=339) (n=339) (n=339) 
Crude estimate  -0.009 (-0.031 - 0.050) 0.072 (0.036 - 0.107)*** 0.005 (0.002 - 0.007)*** 0.004 (-0.001 - 0.007)* 0.005 (0.002 - 0.008)*** 
 R2 = 0.001 R2 = 0.045 R2 = 0.038 R2 = 0.017 R2 = 0.036 
Adjusted estimate   - 0.048 (0.012 - 0.086)*** 0.003 (-0.001 - 0.006)*** 0.004 (-0.001 - 0.007) 0.003 (0.001 - 0.006)*** 
  R2 = 0.167 R2 = 0.149 R2 = 0.050 R2 = 0.169 
      
6-MWT (n=307) (n=307) (n=313) (n=313) (n=313) 
Crude estimate -0.001 (-0.018 - 0.017) 0.023 (0.007 - 0.039)** 0.000 (-0.001 - 0.002) 0.001 (-0.001 - 0.002) 0.001 (-0.001 - 0.002) 
 R2 = 0.000 R2 = 0.026 R2 = 0.008 R2 = 0.002 R2 = 0.007 
Adjusted estimate   - 0.018 (0.008 - 0.032)** - - - 
  R2 = 0.164    
Sit-to-stand 
test 
(n=308) (n=308) (n=314) (n=314) (n=314) 
Crude estimate 0.201 (-0.154 - 0.557) 0.431 (0.111 - 0.750)** 0.045 (0.022 - 0.068)*** 0.041 (0.015 - 0.068)** 0.047 (0.021 - 0.073)*** 
 R2 = 0.004 R2 = 0.022 R2 = 0.046 R2 = 0.029 R2 = 0.038 
Adjusted estimate   - 0.406 (0.105 - 0.706)** 0.042 (0.020 - 0.064)*** 0.039 (0.013 - 0.067)** 0.043 (0.018 - 0.067)*** 
  R2 = 0.184 R2 = 0.183 R2 = 0.054 R2 = 0.200 
Abbreviations: Mean, the mean represents the slope of the best fitted line between the dependent and independent variable;  R2, Coefficient of 
determination; SF-36 MCS, SF-36 mental component scale; SF-36 PCS, SF-36 physical component scale; n, Number of patients;  6-MWT, 6 minutes walk test; 
95% CI, 95 % confidence interval.  
Adjusted estimate; Adjusted for age, sex and patient type 
* p<0.05, **p<0.01,*** p<0.001,  
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To: Larry F. Hamm, Editor-in-Chief of the Journal of Cardiopulmonary Rehabilitation and Prevention. 
 
Dear Editor-in-Chief, 
On behalf of myself and my colleagues, I would like to submit this manuscript to the Journal of 
Cardiopulmonary Rehabilitation and Prevention entitled: Changes in physical performance and their 
association with health related quality of life in a mixed non-ischemic cardiac population.   
The present study investigates whether improvements in physical performance are associated with changes 
in both generic and disease-specific Health-related quality of life (HRQoL).  
Exercise-based CR is known to increase physical performance and HRQoL. However, whether a positive 
improvement in physical performance from exercise-based CR can explain changes in HRQoL is still 
questioned. Previous studies are showing conflicting results and have been mainly conducted using a cross 
sectional design where real changes from the intervention not are taken into consideration.    
The current study is based on data from three randomized controlled trails (the CopenHeart trials).  A total of 
344 non-ischemic heart patients who either were ablated for atrial fibrillation, who underwent heart valve 
surgery or who were treated for infective endocarditis are included. Overall, our findings show that changes 
in physical performance at their highest, only account for 20% of the variation in the HRQoL. Therefore, the 
positive impact that exercise-based CR has on HRQoL cannot simply be explained by an increase in physical 
performance. 
The paper is especially interesting as it is the first to compare real intervention changes obtained from 
different physical outcome measures, to changes in both generic and disease-specific HRQoL. Also, it is the 
largest study to investigate the relationship between physical performance and HRQoL in a mixed 
patient group with non-ischemic cardiac conditions.   
This study is part of the CopenHeart project and is based on three parallel randomized controlled trials that 
meet all national and international regulatory guidelines for clinical trial research. All three trials have been 
approved by the regional Research Ethics Committee (j.nr. H-1-2011-135, j.nr. H-1-2011-129 and j.nr. H-1-
2011-157) and the National Agency for Data Security (j.nr. 2007-58-0015).  
This study is supported by The Danish Council for Strategic Research (number: 10-092790). There are no 
conflicts of interest. All grants were ³non-restricted research grants´ and the funders have no influence on 
the trial design, the execution of the trial or the interpretation of the data.  
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All authors have read and approved submission of the manuscript and the manuscript has not been published 
and is not being considered for publication elsewhere in whole, or part, in any language. It will not be 
submitted elsewhere, until a decision has been made as to its acceptability by the Journal of 
Cardiopulmonary Rehabilitation and Prevention has been made. 
Thank you for taking the time to review this submission. We look forward to hearing from you in due 
course. Should you have any questions regarding this submission, please contact the Principal Author Lars 
Hermann Tang. 
 
Yours sincerely, 
Lars Hermann Tang  
Tel: +45 2535 1341. 
Mail: Lars.Hermann.Tang@rsyd.dk 
